Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Major depressive disorder (MDD) is a serious mental condition that often completely debilitates a
client. MDD is typically treated with one of several currently available antidepressant medications.
However, the response rate to any of these medications is only about 30%. Unfortunately, there are
currently no means for a priori assessment of whether a specific person will respond to a particular
medication. Thus, in prescribing a treatment for MDD, the psychiatrist must by necessity resort to a
trial-and-error procedure. This can result in long delays before remission and significant stress on the
health care system.
In conjunction with collaborating psychiatrists, the applicant has developed a preliminary EEG-based
machine learning (ML) methodology that can predict the response of a person to an SSRI medication
(which is one of the classes of anti-depressant treatment) before the therapy begins. It is clear that
such a capability, when fully developed, will vastly improve the treatment of MDD. However, before
this system can be exploited …
James Reilly
Engineering
Health and Related Sciences & Technology
McMaster University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.